Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891618-98-001349
Filing Date
1998-03-27
Accepted
1998-03-27 00:00:00
Documents
6
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 1997 10-K 239308
2 CONTRACT RESEARCH AND DEVELOPMENT AGREEMENT EX-10.15 89573
3 FIFTH AMENDMENT TO MANUFACTURING AGREEMENT EX-10.16 19178
4 LEASE AGREEMENT DATED NOVEMBER 7, 1997 EX-10.17 293443
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS EX-23.1 713
6 FINANCIAL DATA SCHEDULE EX-27.1 2074
  Complete submission text file 0000891618-98-001349.txt   646313
Mailing Address 550 CALIFORNIA AVE STE 200 PALO ALTO CA 94306
Business Address 550 CALIFORNIA AVE STE 200 PALO ALTO CA 94306 4158427300
COULTER PHARMACEUTICALS INC (Filer) CIK: 0000942416 (see all company filings)

EIN.: 943219075 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21905 | Film No.: 98576182
SIC: 2834 Pharmaceutical Preparations